Synonyms: | |
Status: | Approved (1964) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | A07AA09 |
UNII: | 6Q205EH1VU |
InChI Key | MYPYJXKWCTUITO-LYRMYLQWSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C66H75Cl2N9O24 |
Molecular Weight | 1449.27 |
AlogP | None |
Hydrogen Bond Acceptor | None |
Hydrogen Bond Donor | None |
Number of Rotational Bond | None |
Polar Surface Area | None |
Molecular species | None |
Aromatic Rings | None |
Heavy Atoms | None |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Peptidoglycan inhibitor | FDA |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Protease
Metallo protease
Metallo protease MD clan
Metallo protease M15 family
Metallo protease M15D subfamily
|
- | - | - | 62000 | - | |
Enzyme
Transferase
|
- | 10000 | - | - | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Adrenergic receptor
|
- | - | - | 1000 | - | |
Other cytosolic protein
|
- | - | - | - | 100 | |
Secreted protein
|
- | - | 12000 | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | - | - | 16 | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | - | - | - | 7 | |
Unclassified protein
|
- | - | - | - | 30-30 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Respiratory Tract Infections | 4 | D012141 | FDA |
Sepsis | 4 | D018805 | FDA |
Endocarditis | 4 | D004696 | ClinicalTrials |
Diarrhea | 4 | D003967 | ClinicalTrials |
Enterocolitis | 4 | D004760 | FDA |
Skin Diseases | 4 | D012871 | FDA |
Skin Diseases | 4 | D012871 | ClinicalTrials |
Pneumonia | 3 | D011014 | ClinicalTrials |
Staphylococcal Infections | 3 | D013203 | ClinicalTrials |
Clostridium Infections | 3 | D003015 | ClinicalTrials |
Staphylococcal Skin Infections | 3 | D013207 | ClinicalTrials |
Cellulitis | 3 | D002481 | ClinicalTrials |
Infections | 3 | D007239 | ClinicalTrials |
Cholangitis, Sclerosing | 3 | D015209 | ClinicalTrials |
Pneumonia, Bacterial | 3 | D018410 | ClinicalTrials |
Conjunctivitis, Bacterial | 3 | D003234 | ClinicalTrials |
Diabetic Foot | 3 | D017719 | ClinicalTrials |
Abscess | 3 | D000038 | ClinicalTrials |
Bacteremia | 3 | D016470 | ClinicalTrials |
Osteomyelitis | 3 | D010019 | ClinicalTrials |
Inflammation | 3 | D007249 | ClinicalTrials |
Clostridium Infections | 3 | D003015 | ClinicalTrials |
Gram-Positive Bacterial Infections | 3 | D016908 | ClinicalTrials |
Neonatal Sepsis | 2 | D000071074 | ClinicalTrials |
Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
Prediabetic State | 2 | D011236 | ClinicalTrials |
Joint Diseases | 2 | D007592 | ClinicalTrials |
Cystic Fibrosis | 2 | D003550 | ClinicalTrials |
Obesity | 2 | D009765 | ClinicalTrials |
Pneumonia, Ventilator-Associated | 2 | D053717 | ClinicalTrials |
Constipation | 2 | D003248 | ClinicalTrials |
Crohn Disease | 2 | D003424 | ClinicalTrials |
Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
Pneumonia, Staphylococcal | 2 | D011023 | ClinicalTrials |
Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Peritonitis | 1 | D010538 | ClinicalTrials |
Osteoarthritis | 1 | D010003 | ClinicalTrials |
Renal Insufficiency | 1 | D051437 | ClinicalTrials |
Child Development Disorders, Pervasive | 1 | D002659 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 0 | D002289 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1404-90-6 |
ChEBI | 28001 |
ChEMBL | CHEMBL262777 |
DrugBank | DB00512 |
DrugCentral | 2807 |
EPA CompTox | DTXSID0042664 |
FDA SRS | 6Q205EH1VU |
Human Metabolome Database | HMDB0014653 |
Guide to Pharmacology | 10932 |
PharmGKB | PA451850 |
PubChem | 14969 |
SureChEMBL | SCHEMBL3177 |